We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 41-60 of 399 results
  1. In vitro activity of aztreonam–avibactam against Enterobacterales isolates collected in Latin America, Africa/Middle East, Asia, and Eurasia for the ATLAS Global Surveillance Program in 2019–2021

    This study aimed to report reference method antimicrobial susceptibility results for 24,937 recent (2019–2021) clinical isolates of Enterobacterales...

    Mark G. Wise, James A. Karlowsky, ... Daniel F. Sahm in European Journal of Clinical Microbiology & Infectious Diseases
    Article Open access 01 August 2023
  2. External ventriculostomy-associated infection reduction after updating a care bundle

    Background

    Despite the clinical benefits of external ventricular drains (EVD), these devices can lead to EVD-related infections (EVDRI). The drainage...

    Mariel Rojas-Lora, Luisa Corral, ... Carmen Cabellos in Annals of Clinical Microbiology and Antimicrobials
    Article Open access 15 July 2023
  3. Epidemiology of community origin of major multidrug-resistant ESKAPE uropathogens in a paediatric population in South-East Gabon

    Background

    Urinary tract infections (UTIs) in children are very common. They are often associated with a high risk of sepsis and death. In recent...

    Yann Mouanga-Ndzime, Richard Onanga, ... Cyrille Bisseye in Antimicrobial Resistance & Infection Control
    Article Open access 12 May 2023
  4. High prevalence of MDR gram-negative bacteria in feces of healthy blood donors in Mexico

    During the initial stage of a study to recruit universal intestinal microbiota donors in Mexico City, we found multiple “healthy” subjects that...

    Karla M. Tamez-Torres, Alfredo Ponce-de-Leon, ... Jose Sifuentes-Osornio in European Journal of Clinical Microbiology & Infectious Diseases
    Article 13 March 2020
  5. The role of hospital environment in transmissions of multidrug-resistant gram-negative organisms

    Infections by multidrug-resistant (MDR) Gram-negative organisms (GN) are associated with a high mortality rate and present an increasing challenge to...

    Po Ying Chia, Sharmila Sengupta, ... Kalisvar Marimuthu in Antimicrobial Resistance & Infection Control
    Article Open access 11 February 2020
  6. Comparison of colistin-induced nephrotoxicity between two different formulations of colistin in critically ill patients: a retrospective cohort study

    Background

    Colistin is widely used in the treatment of nosocomial infections caused by carbapenem-resistant gram-negative bacilli (CR-GNB)....

    Jia-Yih Feng, Yi-Tzu Lee, ... Fu-Der Wang in Antimicrobial Resistance & Infection Control
    Article Open access 30 July 2021
  7. New Tetracyclines: Eravacycline and Omadacycline

    The development of tetracyclines began in the 1940s with discovery of the natural product, chlortetracycline. Widespread use over the years led to...
    Chapter 2023
  8. Antimicrobial Resistance: An Overview

    Recounting the struggle against infectious diseases reconciles us with the failures. Following discovery, clinical implementation of different...
    Sheezma Nazir Shah, Mujtaba Aamir Bhat, ... Arif Tasleem Jan in Nanotechnology Based Strategies for Combating Antimicrobial Resistance
    Chapter 2024
  9. Newer Antibiotic Agents in Pipeline

    Multi-drug resistance (MDR) and extensive-drug resistance (XDR) have become common, making care of many patients difficult. The rise in resistance...
    Chapter 2022
  10. Clinical Approach to Treatment of Bacterial Infections

    The determination that a patient has a bacterial infection can be made on the basis of the history, physical examination, and clinical setting, or it...
    Robert W. Finberg, Roy Guharoy in Clinical Use of Anti-infective Agents
    Chapter 2021
  11. Gastrointestinal colonization by OXA-48-producing Enterobacterales: risk factors for persistent carriage

    Carbapenem-resistant Enterobacterales (CRE) infections are a major health problem. Intestinal colonization is a key factor in develo** infection....

    O. Lima, A. Sousa, ... M. T. Pérez-Rodríguez in European Journal of Clinical Microbiology & Infectious Diseases
    Article 07 October 2022
  12. Medical Importance of ESKAPE Pathogens

    Being the ‘escapers’ from the action of antibiotics, the ESKAPE pathogens—Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae,...
    Simi Asma Salim, Mahima S. Mohan, ... Siddhardha Busi in ESKAPE Pathogens
    Chapter 2024
  13. Antimicrobial Resistance: A Crisis in the Making

    Antimicrobial resistance (AMR) is considered the silent pandemic that threatens the global public health systems and one of the biggest threats to...
    Chapter 2023
  14. Short- versus long-course therapy in gram-negative bacilli bloodstream infections

    Bacteremia due to gram-negative bacilli (GNB) is one of the most frequent causes of admission and prolongation of hospital stay. Nevertheless,...

    Adrian Sousa, María Teresa Pérez-Rodríguez, ... Manuel Crespo in European Journal of Clinical Microbiology & Infectious Diseases
    Article 24 January 2019
  15. Ceftazidime–avibactam treatment in bacteremia caused by OXA-48 carbapenemase-producing Klebsiella pneumoniae

    Therapeutic options for bacteremia caused by carbapenem-resistant Enterobacterales (CRE) OXA-48-type are limited. The objective of this study was to...

    O. Lima, A. Sousa, ... MT. Pérez-Rodríguez in European Journal of Clinical Microbiology & Infectious Diseases
    Article 08 August 2022
  16. Phenotypic and genotypic identification of carbapenem resistance in Bacteroides fragilis clinical strains

    Bacteroides fragilis is an important etiological agent of serious infections in humans. Rapid methods, readily adaptable to use in medical...

    Marta Kierzkowska, Anna Majewska, ... Hanna Pituch in Medical Microbiology and Immunology
    Article Open access 13 May 2023
  17. Antimicrobial Therapy

    Any chemical used in treatment, relief or prophylaxis of disease is defined as a chemotherapeutic drug or agent. When chemotherapeutic drugs are...
    Subhash Chandra Parija in Textbook of Microbiology and Immunology
    Chapter 2023
  18. Extensive outbreak of colistin resistant, carbapenemase (blaOXA-48, blaNDM) producing Klebsiella pneumoniae in a large tertiary care hospital, India

    Background

    Extensive drug resistance in Klebsiella pneumoniae ( K. pneumoniae ) causing major outbreaks in large hospitals is an emerging challenge. We...

    Swati Sharma, Tuhina Banerjee, ... Sriparna Basu in Antimicrobial Resistance & Infection Control
    Article Open access 06 January 2022
  19. Nucleic Acid Amplification and Molecular Diagnostic Techniques in the Detection of ESKAPE Bacterial Pathogens

    The word ESKAPE denotes a particular group of microbial species viz., Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumonia,...
    Santhilatha Pandrangi, G. Kishore, ... Suseela Lanka in ESKAPE Pathogens
    Chapter 2024
  20. High frequency and molecular epidemiology of metallo-β-lactamase-producing gram-negative bacilli in a tertiary care hospital in Lahore, Pakistan

    Background

    Metallo-β-lactamase (MBL)-producing isolates have a strong impact on diagnostic and therapeutic decisions. A high frequency of...

    Noor Ul Ain, Anam Iftikhar, ... Saba Riaz in Antimicrobial Resistance & Infection Control
    Article Open access 03 November 2018
Did you find what you were looking for? Share feedback.